Is APRE or ARMP more undervalued in 2026?

CirclFi compares Aprea Therapeutics, Inc. (APRE) and Armata Pharmaceuticals, Inc. (ARMP) using 13 institutional-grade valuation models. APRE has a Quality of Company score of 4.5/10 while ARMP scores 3.5/10.

Which is a better buy — APRE or ARMP?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do APRE and ARMP valuations compare?

APRE at $0.93 and ARMP at $8.12 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

APRE vs ARMP Valuation Comparison 2026 — Intrinsic Value Analysis

APRE

Biotechnology

Aprea Therapeutics, Inc.

Quality

4.5

out of 10

Value Trap

SAFE

Price

$0.93

Last close

Models

8/13

Active

ARMP

Biotechnology

Armata Pharmaceuticals, Inc.

Quality

3.5

out of 10

Value Trap

SAFE

Price

$8.12

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	APRE Fair Value	APRE Upside	ARMP Fair Value	ARMP Upside
Bayesian DCF	Intrinsic	$2.30	+147.6%	$1.04	-87.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.80	-14.3%	$0.87	-89.5%
PWERM	Option-Based	$3.66	+293.6%	$15.46	+90.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for APRE vs ARMP — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

APRE vs ARMP — Which Stock Is More Undervalued?

APRE scores higher with a 4.5/10 quality rating vs ARMP's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Aprea Therapeutics, Inc. (APRE) and Armata Pharmaceuticals, Inc. (ARMP) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

APRE currently trades at $0.93 with a QOC of 4.5/10, while ARMP trades at $8.12 with a QOC of 3.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).